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Voltage-gated sodium channels (VGSCs) are large transmembrane proteins that conduct
sodium ions across themembrane and by doing so they generate signals of communication
between many kinds of tissues.They are responsible for the generation and propagation of
action potentials in excitable cells, in close collaboration with other channels like potassium
channels. Therefore, genetic defects in sodium channel genes can cause a wide variety of
diseases, generally called “channelopathies.”The ﬁrst insights into themechanismof action
potentials and the involvement of sodium channels originated from Hodgkin and Huxley for
which they were awarded the Nobel Prize in 1963. These concepts still form the basis for
understanding the function ofVGSCs.WhenVGSCs sense a sufﬁcient change inmembrane
potential, they are activated and consequently generate a massive inﬂux of sodium ions.
Immediately after, channels will start to inactivate and currents decrease. In the inactivated
state, channels stay refractory for new stimuli and they must return to the closed state
before being susceptible to a new depolarization. On the other hand, studies with neu-
rotoxins like tetrodotoxin (TTX) and saxitoxin (STX) also contributed largely to our today’s
understanding of the structure and function of ion channels and of VGSCs speciﬁcally.
Moreover, neurotoxins acting on ion channels turned out to be valuable lead compounds
in the development of new drugs for the enormous range of diseases in which ion chan-
nels are involved. A recent example of a synthetic neurotoxin that made it to the market
is ziconotide (Prialt®, Elan). The original peptide, ω-MVIIA, is derived from the cone snail
Conus magus and now FDA/EMA-approved for the management of severe chronic pain by
blocking the N-type voltage-gated calcium channels in pain ﬁbers. This review focuses on
the current status of research on neurotoxins acting on VGSC, their contribution to further
unravel the structure and function of VGSC and their potential as novel lead compounds in
drug development.
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VOLTAGE-GATED SODIUM CHANNELS
Likemanyother voltage-gated ion channels,VGSCs are transmem-
brane complexes consisting of a large core protein, the α-subunit
(220–260 kDa, ≈2000 amino acids), associated with one or more
smaller regulatory β-subunits (22–36 kDa). Alpha-subunits con-
tain the functional ion conduction pore as an aqueous cavity that
is selectively permeable for sodium ions. In mammalian cells,
nine α-subunit isoforms (classiﬁed as Nav 1.1–Nav 1.9) have been
characterized so far. Additionally, sodium channel-like proteins,
classiﬁed as Nax, have been identiﬁed but are not yet functionally
expressed (Catterall et al., 2005). The VGSC isoforms are distrib-
uted differentially throughout electrical excitable cells of the body,
which correlates with different functional properties in the cor-
responding tissues. Nav1.1, 1.2, 1.3, and 1.6 are mainly expressed
in the central nervous system (CNS); Nav1.7, 1.8, and 1.9 on the
contrary are highly expressed in the peripheral nervous system
(PNS) and ﬁnally, the Nav1.4 and 1.5 isoforms are present in adult
skeletal muscle and heart muscle, respectively (Goldin, 2001).
In contrast to potassium channels, no crystallographic image
of a sodium channel could be assessed for a long time and
information about the structural composition of the VGSC had
to be deduced in an indirect way. Recently however, the group of
Catterall enlightened the horizon with the determination of the
crystal structure of a bacterial VGSC (Payandeh et al., 2011). In
early molecular cloning studies, later conﬁrmed by cryo-electron
images (Sato et al., 2001) and the recent crystallographic image,
the α-subunit turned out to be composed of four homologous
domains, DI–DIV, which all contain six putative transmembrane
segments, S1–S6 (Yu and Catterall, 2003). The four domains are
connected by three cytoplasmic linker loops of different size and
together they form a bell-shaped protein (Sato et al., 2001).
All of the four domains consist of two modules, the ﬁrst being
the voltage-sensing module formed by S1–4, the second being the
pore-forming module, formed by S5 and S6 and the connect-
ing loop. How the voltage-sensing module can “sense” voltage
and thereby open the channel is a question that can be answered
by looking at one particular segment of this module, the volt-
age sensor S4. These cylindrical α-helical structures display highly
conserved positive residues at every third position. In the “sliding
helix” (Catterall, 1986) or “helical screw” (Guy and Seetharamulu,
www.frontiersin.org November 2011 | Volume 2 | Article 71 | 1
Stevens et al. Neurotoxin binding areas on VGSCs
1986) models these positive charges are proposed to be drawn
into the membrane by the negative internal resting membrane
potential. The positive charges are stabilized by the formation of
neutralizing ion pairs with neighboring negative charges in S1, S2,
and/or S3. When the membrane depolarizes, the negative mem-
brane potential is relieved and the S4 segments move outward,
thereby causing a conformational change that opens the pore and
initiates channel activation (Catterall, 2000, 2010).
Another question that has to be answered when discussing
VGSC’s function is how ion selectivity can be achieved. The answer
lies in the pore region of the channel, formed by S5 and S6 and
the connecting pore-loop (P-loop). By dipping into the mem-
brane, the P-loops of DI–DIV form the outer pore of the channels.
Herein, two rings determine ion selectivity. The inner selectivity
ring is formed by the four amino acids Asp, Glu, Lys, and Ala in
DI, DII, DIII, and DIV, respectively (DEKA-ring). The outer selec-
tivity ring is formed in the same way and is represented by the
residues Glu, Glu, Asp, and Asp of DI, DII, DIII, and DIV, respec-
tively (EEDD-ring). The ﬁrst studies that underlie the discovery
of the DEKA-ring made use of the historical toxins tetrodotoxin
(TTX) and saxitoxin (STX). Their mechanism of action and bind-
ing site is discussed in the following chapter. The intracellular part
of the pore is formed by all four S6 segments (Yu and Catterall,
2003).
Within a few milliseconds after the opening of the channel, fast
inactivation begins. This key feature was the third characteristic
set by Hodgkin and Huxley when they ﬁrst recorded sodium cur-
rents (Hodgkin and Huxley, 1952), besides the voltage-dependent
activation and selective ion conductance. The part of the chan-
nel responsible for fast inactivation is the short, highly conserved
intracellular linker that connects domains III and IV. In mutagen-
esis studies, the three hydrophobic amino acids Ile, Phe, and Met
(IFM motif) turned out to be the key sequence necessary for fast
inactivation. The inactivation gate receptor for this IFM motif is
located within and near the inner mouth of the pore (Smith and
Goldin, 1997).Mutations in the S4 segments, andmore speciﬁcally
S4 of DIV revealed that outward movement of S4 DIV initi-
ates fast inactivation, which makes the inactivation process also
voltage-dependent. This model was largely conﬁrmed by studies
with α-scorpion toxins and sea anemone toxins, of which some
will be discussed later. Another mode of VGSC inactivation was
described as slow inactivation and occurs in a time scale of seconds
after activation, but still remains the topic of further investigations
(Ulbricht, 2005).
The cytoplasmic linker loops between the four domains con-
tinue to be interesting sites at which the channel’s modulation and
regulation of gating processes happen. Several phosphorylation
sites were found in the ﬁrst and third intracellular linkers between
DI–DII and DIII–DIV, respectively. Phosphorylation can be car-
ried out by isoforms of protein kinase A (PKA) or C (PKC) and
has different results on the channels’ function depending on the
kinase or affected VGSC isoform. An ankyrin binding site has also
been identiﬁed in the linker between DII and DIII, which also may
inﬂuence the channels’ gating kinetics (Chahine et al., 2005).
The large α-subunit is associated with one or more smaller
regulatory β-subunits, which modulate sodium currents and also
regulate the cell surface expression of channels (Patino and Isom,
2010). They turned out to be essential pieces of the VGSC com-
plexes as they are needed in the heterologous expression of α-
subunits to display full native sodium channel characteristics, such
as correct kinetics and voltage-dependence of the gating (Yu and
Catterall, 2003). At least ﬁve regulatory β-subunits (β1–β4 and
β1A)have been identiﬁed so far from fourdifferent genes (SNC1B–
4B), with β1A as a splice variant of the β1-subunit. The β-subunits
can be bound either non-covalently (β1- and β4-subunits) or
covalently (β2- and β4-subunits) to form a heteromer with the
α-subunit (Chahine et al., 2005).
NEUROTOXINS AND VGSC PHARMACOLOGY
NEUROTOXINS
From the early beginning of research on the basic principles of ion
channel functioning, neurotoxins fulﬁlled an important job, espe-
cially concerning VGSCs. One particular neurotoxin that deserves
special attention is tetrodotoxin (TTX). It was ﬁrst isolated from
the pufferﬁsh (family of Tetraodontidae) and has a close relative:
saxitoxin (STX). TTX played a great part in the discovery of the
VGSC protein (Agnew et al., 1980) and in the determination of
the selectivity ﬁlter (Heinemann et al., 1992) and binding site 1 for
pore blockers of VGSCs (Noda et al., 1989). Nowadays TTX is still
used to classify sodium channels according to their sensitivity to
TTX: Nav1.5, Nav1.8, and Nav1.9 are TTX-resistant (TTX-R), the
others are TTX-sensitive (TTX-S).
The name “neurotoxin” already reveals at what those natural
chemicals and peptides are best: interfering with the normal func-
tion of the nervous system. That is exactly what plants, animals,
andmicroorganismsdevelop them for: to target a possible offender
or prey, either by immobilizing or immediately killing it. Neuro-
toxins produced by those organisms mostly form part of a mixture
of peptides and enzymes that act in concert. This mixture can be a
venom(peptides andproteins,actively injected andused indefense
or prey acquisition) or a poison (secondary products or metabo-
lites,passively used to protect or defend the organism;Mebs,2002).
But their main target is always the CNS, PNS as herein lie the
vital functions of the offender/prey. During evolution, venomous
and poisonous organisms turned out to be excellent pharmacol-
ogists since their toxins evolved to be highly speciﬁc for targets
in the CNS or PNS. They can act on membrane receptors and
ion channels like voltage-gated sodium, potassium, and calcium
channels. By doing so they give us outstanding keys to investigate
the structure and function of their targets, to deﬁne underly-
ing physiological processes, and most importantly, to design new,
potent, and selective drugs useful in a wide variety of diseases like
pain, diabetes, and multiple sclerosis (Lewis and Garcia, 2003). As
an example of a rich and nearly unexplored library of valuable
bioactive compounds, one can look at cone snails, which are ven-
omous marine invertebrates. More than 700 species are known
to date and it is estimated that a single Conus species may con-
tain up to 200 different venom peptides, implying that a library of
more than 140,000 compounds of possible pharmaceutical inter-
est is available in their venom. At least one compound has led
to a new therapy for severe chronic pain (ziconotide/Prialt®) and
many other lead compounds can be suspected from these and
other venomous and poisonous organisms (Terlau and Olivera,
2004).
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NEUROTOXIN BINDING
Neurotoxins acting on VGSCs can aim at six different sites in the
channels, distinguished not only by matters of localization of the
toxin binding place but also by the results of the toxin’s action.
Apart from the neurotoxin receptor sites, two other sites are deter-
mined. The pyrethroid binding site is the binding site for some
insecticidal agents like DDT and pyrethroids. Anticonvulsants and
antiarrhythmics bind in a use-dependentmanner to the local anes-
thetics (LA) site (Table 1). The latter two will not be discussed
in this review because they are not affected by neurotoxins and
therefore, are not in the scope of this review.
The interaction between neurotoxins and VGSCs can occur
in two different ways. It either results in a pore block when the
toxin physically occludes the pore and thereby inhibits the sodium
conductance, or in a modiﬁcation of the gating, which leads to
altered gating kinetics and voltage-dependence of the channels.
Toxins binding on site 1 use the ﬁrst mechanism. The previously
mentioned guanidinium toxins TTX and STX are such site 1 pore
blockers; they will form a plug in the outer vestibule of the pore.
Site 2 toxins like batrachotoxin and grayanotoxinwill prevent inac-
tivation and therefore persistently activate the channel. Scorpion
α-toxins and sea anemone toxins are typical examples of site 3 tox-
ins; they will slow or inhibit inactivation. Scorpion β-toxins and
β-spider toxins bind to site 4 and shift the voltage-dependence of
activation towardmore hyperpolarizedpotentials. Site 5 neurotox-
ins like brevetoxins and ciguatoxins exhibit a real arsenal of effects
upon VGSC binding, e.g., inhibition of activation and a hyper-
polarizing shift of the voltage-dependence of activation. Lastly,
δ-conotoxins acting on site 6 will cause similar effects as site 3
toxins by slowing or inhibiting inactivation (Figure 1 and Table 1).
As mentioned previously, toxins can be differentiated based
on their chemical composition. Organic hydrophilic or lipophilic
neurotoxin compounds are mostly secondary metabolites, used
by the producing organism as defense molecules. Examples of
lipophilic compounds include the site 2 grayanotoxins and the
brevetoxins acting on site 5. Hydrophilic secondary metabolites
include site 1 toxins TTX and STX. On the other hand, organ-
isms can use larger chemical entities like peptides to paralyze or
kill their prey, like the peptides found in scorpions, spiders, wasps,
cone snails, and others. But although their origin might be differ-
ent, both kinds of neurotoxins can have the same effect (binding
of μ-conotoxins and TTX for both results in block of the Na+
conductance). For other reviews on neurotoxins acting on VGSCs
see for example (Catterall et al., 2007; de laVega and Possani, 2007;
Billen et al., 2008; Andavan and Lemmens-Gruber, 2011).
NEUROTOXIN BINDING SITE 1
Among all putative binding sites on VGSCs, site 1 is probably the
best deﬁned and most straightforward of all sites. It is composed
by residues at the reentrant P-loops connecting S5 and S6 of all
four domains. The historical guanidinium molecules TTX and
STX were the ﬁrst neurotoxins shown to bind at this site. Upon
their binding, Na+ conductance is blocked. They are produced by
some bacteria and dinoﬂagellate species, respectively (Narahashi,
2008; Chau et al., 2011). Later on, the μ-conotoxins found in cone
snails, also turned out to bind to this speciﬁc site and to cause the
same effects. At ﬁrst it was thought that both types of toxins would
interact with exactly the same residues but it seems to be a more
complex interplay, as some mutations in Nav1.4 channels affecting
TTX binding did only affect binding of a μ-conotoxin to a minor
extent. Therefore, it was suggested that TTX and μ-conotoxins
share an overlapping but non-identical binding site (Stephan et al.,
1994). In this model, the core of the binding site is situated more
in the inner side of the pore mouth and can be occupied by TTX
Table 1 | Overview of neurotoxin binding sites according to the revised model.
Site Neurotoxins Examples Peptide Main binding area
known up to date
Result
1 Guanidinium toxins TTX, STX – DI–IV P-loop Block of Na+ conduction
μ-Conotoxins KIIIA, SIIIA, PIIIA x
2 Small lipid-soluble toxins Batrachotoxin – DI DIV S6 Negative shift in voltage-dependency of activation
Veratridine – Slowing down of inactivation
Grayanotoxins – Block of Na+ conductance
Aconitine – Altering ion selectivity
3 Scorpion α-toxins AaH II, LqhaIT, BMK M1 x DIV S3–S4 Slowing down of inactivation
Sea anemone toxins ATX-II, AFTII x
4 Scorpion β-toxins Css4, Tsγ, AahIT x DII S3–S4 Negative shift in voltage-dependency of activation
Spider β-toxins Magi 5, HWTX-IV x Block of Na+ conductance
μO-conotoxins MrVIA x
5 Cyclic polyether compounds Brevetoxins – DI S6 Negative shift in voltage-dependency of activation
Ciguatoxins – Slowing down of inactivation
6 δ-Conotoxins x DIV S4 Slowing down of inactivation
7 Pyrethroids DDT, Deltamethrin – DII–DIII Slowing down of inactivation
LA Local anesthetics Lidocaine – DIV S6 Block of Na+ conduction
Anticonvulsants –
Antiarrhythmics –
Antidepressants –
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FIGURE 1 | Schematic two-dimensional representation of the functional α-subunit of voltage-gated ion channels and identification of known
neurotoxin binding areas.
or STX as well as μ-conotoxins, the latter interacting with some
extra residues laying at the outer vestibule of the pore. Recently,
another TTX/μ-conotoxin binding model was proposed in which
TTX, STX, and the μ-conotoxins were suggested to be “syntox-
ins,” acting on adjacent sites in the VGSCs and inﬂuencing each
other’s binding kinetics. Zhang et al. (2009) ﬁrst proposed the
simultaneous binding of TTX and KIIIA, a μ-conotoxin from
Conus kinoshitai. Addition of both toxins to oocytes expressing
Nav1.2 leads to the formation of a bi-liganded, ternary complex of
Nav·TTX/alkaloid·μ-conotoxin. If KIIIAbinds ﬁrst to the channel,
this will slow the subsequent binding of TTX at its speciﬁc binding
place, further down into the channel; and the other way around.
But in another series of experiments done by the same group, this
appeared not to be completely true for STX and its sulfated con-
gener GTX2/3. Another, extended model was suggested, wherein
the binary complex Nav·μ-conotoxin could ﬂicker between a per-
missive state, inwhich the alkaloid can“sneak”by theμ-conotoxin,
and an unpermissive state (French et al., 2010; Zhang et al., 2010).
Because STX has an extra positive charge compared with TTX,
this could lead to electrostatic repulsion. The authors also checked
this model with a docking model based on the current homology
model for VGSCs. This was developed by Lipkind and Fozzard
(2000), based on the crystal structure of the bacterial potassium
channel KcsA. Docking of TTX and KIIIA was consistent with
their experimental results; both molecules do ﬁt simultaneously
in the vestibule.
The VGSC homology model previously turned out to be valu-
able to deﬁne the structure of the outer channel vestibule (Cer-
venka et al., 2010). Although the outer vestibule was long time
believed to be a rigid structure, this does not correspond to the
large amount of studies that predict a highly ﬂexible P-loop that
even might undergo conformational changes that are linked to
gating transitions upon binding of TTX or μ-conotoxins. This
can be deduced, amongst other things, from mutagenesis studies
examining the effects of mutations in this region. Those muta-
tionsmostly correlatedwith alterations in gating kinetics andmore
speciﬁcally decreased (mutations in the P-loop of DI) or enhanced
inactivation (mutations in the P-loop of DIV; for a review see Cer-
venka et al., 2010). The latter can be explained by the proximity
of DIV S6 to the P-loop of DIV, as DIV S6 plays an important
role in the inactivation process. Moreover, this DIV S6 segment
is supposed to enclose the binding site of LA, which on its turn
connects site 1 and 6. Site 1 toxins such as μ-conotoxins can also
inﬂuence the activationprocess by interactingwith the voltage sen-
sors. μ-Conotoxins such as KIIIA and GIIIA are strongly cationic
peptides. Upon binding at site 1, these peptides electrostatically
impede the outward movement of the positively charged residues
in the S4 voltage sensor segments, which is a necessity for channel
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activation. The electrostatic repulsion, induced by binding of the
toxin at site 1, most probably stabilizes the closed state, result-
ing in channels which will open at more depolarized membrane
potentials (French et al., 1996; Van Der Haegen et al., 2011).
Another neurotoxin believed to affect site 1 is Tx1 fromPhoneu-
tria nigriventer (Martin-Moutot et al., 2006). Though binding of
labeled Tx1 was not inhibited by TTX, it was inhibited by the μ-
conotoxin GIIIB (Conus geographus). Therefore it was suggested
that Tx1, like TTX, binds to a micro site and that the binding site
of μ-conotoxins overlaps the micro sites of TTX and Tx1. So far,
only one other spider toxin is known to interact with binding site
1, that is Hainantoxin-I (HNTX-I) from Ornithoctonus hainana
(Li et al., 2003). Other spider toxins like Huwentoxin-IV (HWTX-
IV) from Ornithoctonus huwena and some Hainantoxins (HNTX
III-V) were at ﬁrst considered to be potential site 1 neurotoxins
as they inhibit Na+ conductance, an effect concerned to be typi-
cal for site 1 (Li et al., 2003; Nicholson, 2007). The same is valid
for μO-conotoxins; but this hypothesis had to be adjusted as evi-
dence occurred that these toxins do not bind to residues at site 1
but at residues in S3–S4 of DII (Leipold et al., 2007). Intriguingly,
these residues form part of what is generally determined as“site 4.”
Together with other recent similar ﬁndings concerning the other
“traditional” neurotoxin binding sites, this prompted us to con-
sider a revision of the binding sites. Therefore the latter toxins will
be discussed into more detail in the section about the revision of
the binding sites.
NEUROTOXIN BINDING SITE 2
This site is targeted by a wide array of lipid-soluble toxins
with greatly diverting chemical structures. Their structural non-
relatedness is mirrored in their diverse source of origin as they can
be found in plants, animals, and bacteria.Well-known examples of
site 2 toxins from plants are alkaloids like veratridine (VTD; from
Liliaceae) and aconitine (Aconitum napellus) and grayanotoxins
(GTX) fromEricaceae. Batrachotoxin (BTX) andhomologs are site
2 toxins produced by animals such as frogs (Phyllobates spp.) and
birds (Pitohui and Ifrita spp.; Dumbacher et al., 2000). Recently,
antillatoxin and hoiamide were isolated from some cyanobacte-
ria (Lyngbya majuscula) and were found to bind to neurotoxin
receptor site 2 (Pereira et al., 2009; Cao et al., 2010).
Site 2 toxins are known as activators as they modulate sodium
channels in such a way that the channels open more easily and
stay open longer. Activators preferentially bind to channels in the
open state and their binding leads to Nav channels with a unique
and complex behavior (Hille, 2001). Several channel properties
are altered upon site 2 binding: (i) the voltage-dependence of
activation is shifted towardmore negative potentials causing chan-
nels to open at resting potentials; (ii) the inactivation is slowed
down or inhibited resulting in sustained, non-inactivating cur-
rents; (iii) the sodiumconductance through toxin-bound channels
is reduced; (iv) the ion selectivity of modiﬁed channels is altered
due to a decreased discrimination for permeating ions (Tikhonov
and Zhorov, 2005; Du et al., 2011). Numerous studies have been
conducted to map the neurotoxin site 2 and to provide a better
understanding of themolecular determinants responsible for these
intriguing channel gating alterations upon toxin binding. Stud-
ies using photo-labeled BTX identiﬁed the ﬁrst residues within
the inner helixes of DI S6 (I433, N434, and L437) and DIV S6
(F1579 and N1584) that are crucial for BTX binding in Nav1.4
(Wang and Wang, 1998, 1999). The key role of these residues in
BTX binding was conﬁrmed as point mutations of the equiva-
lent residues in Nav1.5 rendered these channels insensitive to BTX
(Wang et al., 2007). Although site 2 is believed to be localized
mainly at the S6 of DI and DIV, site-directed mutagenesis stud-
ies have shown that speciﬁc amino acid residues among all four
S6 segments are contributing to the neurotoxin receptor site 2
(Wang et al., 2000, 2001). The exact location of all known molecu-
lar determinants contributing to the BTX binding site has recently
been well summarized (Du et al., 2011).
The observed channel gating alterations upon binding to site
2 used to be explained by an allosteric model in which the lipid-
soluble toxins bind at lipid-exposed sites distinct from the pore
or the voltage sensors (Catterall et al., 2007). Even though this
model of allosteric interactions provided a reasonable interpre-
tation of modiﬁcations in ion selectivity, channel gating, and
conductance at the time, an increasing number of studies have
emerged the necessity to revise this model. Although the exact
molecular mechanism of action is still poorly understood, there
is increasing evidence suggesting that these toxins bind within the
pore rather than at the lipid-exposed channel interface (Tikhonov
and Zhorov, 2005; Du et al., 2011). Recently, a new model, which
is consistent with most studies on BTX binding, has been pro-
posed (Du et al., 2011). In this model, activators such as BTX
bind within the inner pore with residues in the S6 segments of all
four domains, exposing the activator directly to the permeation
pathway. This model conﬁrms the previous hypothesis that the
observed inhibition of inactivation might be due to BTX interac-
tion with the above-described residues in S6 of DIV. The DIV S6
segment is not only involved in fast inactivation, as it can also be
seen that altered movements of toxin-bound S6 segments inﬂu-
ence the movement of adjacent segments. Therefore, it is possible
that BTX binding alters the voltage-dependent movement of the
DIV S4 voltage sensor and thereby modiﬁes channel activation
and its coupling to inactivation (Linford et al., 1998; Catterall
et al., 2007). The reduced sodium conductance can be seen as the
outcome of a narrower Na+ binding site due to the presence of a
BTX molecule in the inner pore. In contrast, the altered ion selec-
tivity could be a direct consequence of a wider selectivity ﬁlter
in modiﬁed channels. It has been well established that the DEKA
locus within the selectivity ﬁlter determines the sodium channel
selectivity. Moreover, K1422 can be seen as a key residue since
a point mutation of this residue into a glutamic acid conferred
calcium conducting characteristics onto sodium channels (Heine-
mann et al., 1992). The new BTX binding model suggests that
BTX does not interact directly with the DEKA locus but rather
causes a deﬁciency of water molecules in the proximity of the
selectivity ﬁlter. The displacement of water molecules may lead
to a shift in the PKA of the ion selectivity-determining residue
K1422 and in this way, lower the discrimination in permeating
ions (Du et al., 2011). Although this model is consistent with
most available experimental data, it should be noted that there
are limitations to homology models and that more experiments
are required to conﬁrm the theoretical analysis of this BTXbinding
model.
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Several studies have contributed in locating the binding site
for the lipid-soluble grayanotoxins. Similar to the BTX binding
residues, it was found that S251, I433, N434, L437, I1575, F1579
on Nav1.4 and their equivalents on the cardiac sodium channel
Nav1.5 are involved in the binding of GTXs (Ishii et al., 1999;
Kimura et al., 2001). Mutation of one speciﬁc residue at position
1586 inDIVS6 completely abolished grayanotoxin-induced effects
on Nav1.4 channels. Remarkably, the same mutation did not alter
BTX binding (Kimura et al., 2000). Altogether it can be concluded
that the GTX binding site is not completely identical to the BTX
binding site but is overlapping as they share numerous molecular
determinants.
In contrast with BTX, the channel modulation by veratridine
is less investigated. In general it is assumed that VTD binds at the
same site as BTX since VTD induces channel alterations that are
similar to these of BTX (Wang and Wang, 2003). However, con-
trary to BTX, which does not dissociate from its receptor, VTD
binding is reversible and it does dissociate from its receptor upon
membrane hyperpolarization (Ulbricht, 1998). More recently, a
bell-shaped relationship was described between the concentration
of veratridine and the sodium current peak amplitude in murine
vas deferens myocytes. It was observed that increasing concentra-
tions of VTD enhance the peak amplitude, reaching a maximum
around 10μM while higher concentrations of VTD reduced the
sodium conductance (Zhu et al., 2009).
The effects of aconitine still remain poorly studied. However, it
is known that aconitine binding causes an incompletion of inac-
tivation and an alteration of the ion selectivity in muscle VGSCs
but not in nerve ﬁbers (Campbell, 1982; Wang and Wang, 2003).
NEUROTOXIN BINDING SITE 3
Neurotoxins binding to site 3 include members of different phyla
of the kingdom of Animalia, among which major players are tox-
ins from scorpions, sea anemones, and spiders. In fact, binding
site 3 was ﬁrst determined by radiolabeling and mutagenesis stud-
ies performed with α-scorpion and sea anemone toxins (Tejedor
and Catterall, 1988; Rogers et al., 1996). Scorpion toxins affecting
the gating of VGSCs are historically classiﬁed into α- and β-toxins
according to the effects that they cause. β-Scorpion toxins cause
a strong hyperpolarizing shift in the voltage-dependence of acti-
vation, which is linked to neurotoxin binding site 4 and will be
discussed in the following chapter. α-Scorpion toxins are long
polypeptides of 60–70 amino acids and can be further subdivided
into three groups according to their phylogenetic speciﬁcity (Gor-
don et al., 1996; Hamon et al., 2002). Classical α-scorpion toxins
or anti-mammalian toxins will inhibit inactivation of mammalian
VGSCs and have low afﬁnity for insect neuronalmembranes.Well-
known examples are AaH II (Androctonus australis Hector; Jover
et al., 1978) and Lqh II (Leiurus quinquestriatus hebraeus; Sautiere
et al., 1998). Anti-insectα-scorpion toxins like LqhaIT (Eitan et al.,
1990) only showminor activity againstmammalian brain prepara-
tions but do show signiﬁcantly higher inhibition of insect VGSCs.
Finally, α-like scorpion toxins bind to both rat brain and insect
VGSCs (e.g., BMK M1 (Hamon et al., 2002; Sun et al., 2003).
The second class of toxins that are famous for inhibiting VGSC
inactivation is found in the venom of sea anemones. Sea anemone
toxins targeting VGSCs are subdivided into several classes, but
unlike α-scorpion toxins, this classiﬁcation is not based on their
phylogenetic preferences but on their amino acid sequences. Nor-
ton (1991) ﬁrst proposed three classes to which a sea anemone
toxin can belong. Type 1 and 2 toxins include larger peptides,
composed of 46–49 amino acids and 3 disulﬁde bridges. Type 3
toxins are shorter peptides, composed of 27–30 amino acids only
(Honma and Shiomi, 2006; Bosmans and Tytgat, 2007; Shiomi,
2009). Besides toxins from scorpions and sea anemones, site 3 is
also targeted by toxins from other animals like spiders (e.g., δ-
atracotoxins, Nicholson et al., 2004; Tx4(6-1), de Lima et al., 2002;
and Magi 4, Corzo et al., 2003) and wasps (e.g.,β-PMTX, Schiavon
et al., 2010).
Parts of the VGSCs that were ﬁrst identiﬁed to be involved in
the binding of site 3 neurotoxins were located in the extracellular
loops between S5 and S6 in DI and DIV (Thomsen and Catterall,
1989). Later on, residues in the extracellular loop between S3 and
S4 in DIV also turned out to be involved in the binding of site
3 neurotoxins (Rogers et al., 1996). Fluorescence labeling studies
indicated that site 3 neurotoxins stabilize the voltage sensor S4
of DIV in its deactivated position, thereby inhibiting its move-
ment (Campos et al., 2008). As S4 of DIV is known to be involved
in the voltage-dependent coupling between activation and fast
inactivation (Chahine et al., 1994; Sheets and Hanck, 1995), it is
logic that neurotoxin binding to this site causes an impairment
of the fast inactivation. The inactivation can be slowed or even
completely abolished and these effects can be associated with a
minor hyperpolarizing shift in the activation. It was also shown
that site 3 neurotoxins enhance the recovery from inactivation
(e.g., work with the α-scorpion toxin Ts3 from Tityus serrulatus,
Campos et al., 2004; and Anthopleurin B from the sea anemone
Anemonia xanthogrammica, Sheets and Hanck, 1995). Another
important characteristic is the voltage-dependency of the bind-
ing of these neurotoxins, such that they bind to a lesser extent at
more depolarizing potentials (Catterall, 1977).
Site 3 neurotoxins turned out to be interesting tools for the
investigation of gating currents, which are small transient currents
that occur by movement of gating charges, mostly located on the
S4 segments of the channel (Bezanilla, 2000). Via measurements
of gating currents one can obtain much information about the S4
voltage sensors in ion channels and their contribution in sensing
membrane potential. Sea anemone toxins ATX-II from Anemonia
sulcata (Neumcke et al., 1985) and Anthopleurin A from Anemo-
nia xanthogrammica (Sheets and Hanck, 1995) both reduced the
maximum gating charge of VGSC and via mutagenesis studies it
could nicely been demonstrated that this reduction resulted specif-
ically from the inhibition of S4 of DIV, indicating clearly the main
binding site of these toxins (Sheets et al., 1999).
The prior mentioned α-scorpion toxins, sea anemone toxins
and spider toxins have all been shown to bind to the conven-
tional site 3 and exert their conventional site 3 action: slowing
or inhibiting the VGSC’s fast inactivation. Recently however, this
traditional view on site 3 was samewise challenged as with site
1, as the δ-palutoxins (from the spider Paracoelotes luctuosus)
were suggested to bind to site 4, although they exhibit actions
that are typical for site 3 neurotoxins (Corzo et al., 2005; Ferrat
et al., 2005). Another study with some other spider toxins gain-
ing similar unexpected ﬁndings related with binding sites is the
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electrophysiological characterization of β/δ-agatoxins, originating
from Agelena orientalis (Billen et al., 2010). It has been shown
by Billen et al. that these toxins affect, in a voltage-dependent
manner, both the inactivation process (site 3 effect) and the acti-
vation process (site 4 effect). These results even more questioned
the generally accepted deﬁnition of “site 3” and the concepts of
binding sites in general. The latter toxins will be discussed in the
section about the revision of the binding sites, together with the
unconventional site 1 neurotoxins.
NEUROTOXIN BINDING SITE 4
Receptor site 4 is recognized by the class of β-scorpion toxins tar-
geting voltage-gated sodium channels (βNaScTxs) and by several
spider toxins. These toxins exert their toxicity by acting as gating
modiﬁers. Toxin binding at site 4 causes a shift in the voltage-
dependence of activation toward more hyperpolarized membrane
potentials and reduces the peak sodium current amplitude (Vijver-
berg and Lazdunski, 1984; Cestele et al., 2006). These alterations
in channel gating are believed to be a direct result of toxin binding
at site 4, hereby trapping the voltage sensor in its outward, acti-
vated position (Cestele et al., 2001, 2006). Receptor site 4 has been
primarily deﬁned to speciﬁc residues in the extracellular loops
connecting the S1–S2 and S3–S4 segments of DII (Catterall et al.,
2007). However, using the scorpion β-toxin Tz1 (Tityus zulianus)
it was shown that three residues in the pore-loop of DIII are deter-
mining for the speciﬁcity of β-toxin for different sodium channel
isoforms (Leipold et al., 2006). A recent report showed that spe-
ciﬁc mutations in the voltage sensor of DIII enhance the binding
of β-toxins to S4 of DII, providing evidence for the involvement
of the DIII voltage sensor in the action mechanism of βNaScTxs
(Song et al., 2011).
Toxins belonging to the class of βNaScTxs are long chain pep-
tides composed of 58–76 amino acids, cross-linked by four disul-
ﬁde bridges. They belong to the structural superfamily of cysteine
stabilized α/β motif containing proteins. This spatially conserved
scaffold provides βNaScTxs with a high stability and a strong resis-
tance against mutations in their sequence (Possani et al., 1999;
de la Vega and Possani, 2007; Gurevitz et al., 2007). βNaScTxs
are, similar to their αNaScTxs counterparts, classiﬁed into three
groups according to their pharmacological properties exempliﬁed
by their preference for mammalian or insect sodium channels:
mammalian-selective, β-like or insect-selective. (i) Mammalian-
selective β-toxins such as Css4 (Centruroides suffusus suffusus) are
highly toxic to mammals (Martin et al., 1987). (ii) β-like toxins are
capable of competing for binding sites on both insect and mam-
malian Nav channels. Tsγ, also known as Ts1 or Ts VII (Tityus
serrulatus) and Lqhβ1 (Leiurus quinquestriatus hebraeus) are well-
studied examples of such βNaScTxs acting on both insects and
mammals (Possani et al., 1999; Gordon and Gurevitz, 2003). (iii)
Insect-selective β-toxins fail to exert any afﬁnity whatsoever for
mammalian sodium channels, even in very high concentrations
(de Dianous et al., 1987). Exactly this complete lack of mammal
activity combined with their strong insect speciﬁcity and potency
makes these insect-selective βNaScTxs interesting lead compounds
in the design of new insecticides (Gurevitz et al., 2007).
The insect-selective β-toxins can be further subdivided into
excitatory and depressant toxins according to the symptoms they
evoke in vivo. Injection of excitatory toxins induces a fast repet-
itive activity of motor nerves that results in a reversible con-
traction paralysis. AahIT (Androctonus australis Hector), LqqIT1
(Leiurus quinquestriatus quinquestriatus) and Bj-xtrIT (Hotten-
totta judaicus, formerly known as Buthotus judaicus) belong to this
group (Froy et al., 1999; Billen et al., 2008). These excitatory toxins
differ from the other β-toxins as one disulﬁde bridge is located dif-
ferently and furthermore they display extra secondary structural
elements. The depressant toxins cause a transient contraction fol-
lowed by a slow depressant and ﬂaccid paralysis (Zlotkin et al.,
1991; Karbat et al., 2007). Current-clamp experiments have shown
that peptides belonging to this group suppress the evoked action
potentials as a result of strong depolarization of the membrane
(Strugatsky et al., 2005). Representatives of this group are LqqIT2
(L. q. quinquestriatus), BjIT2 (H. judaicus), and the highly potent
toxin Lqh-dprIT3 (L. q. hebraeus; Zlotkin et al., 1993). It is inter-
esting to note that LqqIT2 did not only cause a hyperpolarizing
shift in the activation of channels but also affected the inactiva-
tion and the ion selectivity (Bosmans et al., 2005). Remarkably,
when mammalian channels are excited by a long, precondition-
ing and depolarizing prepulse, insect-selective depressant β-toxins
are given the opportunity to affect those channels. The same phe-
nomenon is observed in the case of simultaneous binding of an
α-toxin to site 3 (Cohen et al., 2007). As such, it can be seen that
the presence of depressant β-toxins in the scorpion venom may
still contribute signiﬁcantly to the toxicity toward mammals.
Spiders are, similar to scorpions, capable of producing toxins
that recognize the neurotoxin receptor site 4. Magi 5 (Macrothele
gigas) was the ﬁrst spider toxin shown to compete with the
radioiodinated scorpion β-toxin 125I-CssIV for site 4 (Corzo
et al., 2003). Another group of site 4 spider toxins is constituted
by the δ-palutoxins (P. luctuosus), curtatoxins (Hololena curta),
μ-agatoxins (Agelenopsis aperta), and the recently characterized
β/δ-agatoxins (A. orientalis; Stapleton et al., 1990; Corzo et al.,
2000; Billen et al., 2010). All peptides belonging to this group are
structurally related as they are composed of 36–37 residues and
cross-linked by four disulﬁde bridges forming an inhibitor cystine
knot (ICK) motif (Nicholson, 2007). Little is known about the
mechanism of action of the curtatoxin but the highly homologous
μ- and β/δ-agatoxins and δ-palutoxins have been well-studied.
It was reported that the μ-agatoxins shift the voltage-activation
curve toward more hyperpolarized potentials, like scorpion β-
toxins do. However, these toxins also slowed down the inactivation
process of the sodium channels, resulting in a non-inactivating
persistent current (Adams, 2004). The same observations were
made for the β/δ-agatoxins and a thorough electrophysiological
characterization of the action of these agatoxins was performed.
This indicated that β/δ-agatoxins induce a bell-shaped voltage-
dependentmodulation of both the activation and the inactivation,
suggesting no strict correlation between the toxin binding site and
its effect on channel gating (Billen et al., 2010). The δ-palutoxins
compete with the depressant scorpion β-toxin Bj-xtrIT for site 4
but they fail to displace the binding of α-toxin LqhαIT from site
3 (Corzo et al., 2005). However, these toxins act as insect-selective
modulators of sodium channels by slowing down the inactivation,
a modulation typically seen upon toxin binding at site 3 (Corzo
et al., 2000). All together these results indicate that βNaScTxs and
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their spider homologs should be considered as macromolecular
ligands that may have additional contact points with the extracel-
lular domains of VGSCs, in addition to the neurotoxin receptor
site 4. More details can be found in the section about the revision
of the binding sites.
NEUROTOXIN BINDING SITE 5
Marine dinoﬂagellates produce highly lipophilic, cyclic polyether
compounds which target the neurotoxin receptor site 5. Breve-
toxins (Karenia brevis) and ciguatoxins Gambierdiscus toxicus) are
such multi-ring polyether ladder toxins acting at site 5. Breve-
toxins (PbTxs) consist of 11 transfused rings, 23 stereocenters
and an overall linear low-energy conformation (Jeglitsch et al.,
1998). PbTx-1 and PbTx-2 are two most potent brevetoxins and
they are considered to be the parent toxins. Up to date at least
14 brevetoxins have been described. The two most potent breve-
toxins are PbTx-1 and PbTx-2 that slightly differ from each other
in their backbone structure. PbTx-1 and PbTx-2 are considered
parent toxins since all other brevetoxins can be seen as derivates
from one of these two structural backbones. All PbTxs possess a
lactone in the A-ring and a strictly rigid region that forms a lad-
der structure and which is separated from the A-ring by a spacer
region with limited ﬂexibility (Gawley et al., 1995). Furthermore,
they all possess a side chain that allows modiﬁcation at the mole-
cules’ termini (Baden et al., 2005). PbTxs interact with VGSCs by
intercalating in the membrane in a head-down orientation. Sev-
eral studies have indicated that these toxins position themselves
across the plasma membrane, parallel with the transmembrane
segments, with the A-ring toward the intracellular side and the tail
end of the molecule facing the extracellular side (Trainer et al.,
1994; Jeglitsch et al., 1998). Experiments, in which a photoreactive
PbTx-3 derivate was used as probe, could identify S6 of DI and
S5 of DIV to participate in the formation of neurotoxin recep-
tor 5 (Trainer et al., 1994). However, the key residues involved
in brevetoxin activity still remain unknown. PbTx binding at site
5 leads to distinct alteration in channel gating: (i) the activation
potential is shifted toward hyperpolarized potentials; (ii) channels
remain longer in the open conﬁguration which results in a longer
mean open time; (iii) the inactivation is slowed down or inhibited;
and (iv) brevetoxins have, among all known voltage-gated sodium
channel modifying toxins, the unique capability to stabilize more
than one conductance level. As such brevetoxin binding induces
distinct sodium ion subconductance states in addition to the nor-
mal 21 pS rate (Schreibmayer and Jeglitsch, 1992; Jeglitsch et al.,
1998; Baden et al., 2005). It is believed that the terminal, rigid four
ring system is involved in channel binding while the functional
lactone A-ring is responsible for the alterations in channel inacti-
vation and prolongation of the mean open time (Jeglitsch et al.,
1998; Purkerson-Parker et al., 2000).
Ciguatoxins (CTXs) are, like brevetoxins, lipid-soluble com-
pounds with a structural backbone composed of 13 ether rings
(Yasumoto, 2001). Although 29 ciguatoxin derivates have been
identiﬁed, the information on their biological activity remains
scarce, mainly due to difﬁculties in obtaining pure toxin (Perez
et al., 2011). They compete with brevetoxins for site 5 and upon
binding CTXs do cause similar modiﬁcations of channel gat-
ing. CTXs shift the activation of channels toward more negative
potentials and they suppress the fast inactivation. Even though
they bind at the same neurotoxin receptor, PbTxs and CTXs pos-
sibly differ from each other in their mechanism of action. This
was ﬁrst suggested by the observation that CTXs were, unlike
PbTxs, capable of producing Nav dependent oscillations in neu-
ronal membrane potential (Hogg et al., 2002). More recently it
was shown that CTX causes a concentration-dependent decrease
of the sodium current amplitude in mammalian sensory neurons.
This observation is in contrast to the observed amplitude increase
after PbTx application (Cohen et al., 2008; Yamaoka et al., 2009;
Perez et al., 2011).
NEUROTOXIN BINDING SITE 6
Among all sites, site 6 still is themost speculative and yet undeﬁned
site. A ﬁrst proposal for this site arose when TxVIA and GmVIA,
δ-conotoxins from the cone snails Conus textile and Conus gloria-
maris respectively,were characterized (Fainzilber et al., 1994; Shon
et al., 1994). As they turned out to slow down VGSC inactivation
without the typical voltage-dependency that is seen with classical
site 3 toxins, it was suggested that they bind to a novel, unidentiﬁed
site (Fainzilber et al., 1994). Todate, 19 δ-conotoxins sequences can
be found in the ConoServer database (Kaas et al., 2008), but for
none of them the exact binding site has been reported. Only for δ-
SVIE an interaction with conserved residues in the linker between
S3–S4 of DIV was shown (Leipold et al., 2005). This indicates that
at least the S3–S4 of DIV is involved in the interaction of the toxin
andVGSC. It remains to be determined if this is a general phenom-
enon and if δ-SVIE is a good representative of all δ-conotoxins, or
if a difference exists between the two distinct groups that exist
in δ-conotoxins. Those two groups or “clades” are based on the
prey targeted by the according cone snail: namely the ﬁsh-hunting
clade and the mollusk-hunting clade, as structural differences can
be recognized between both groups (Bulaj et al., 2001). However,
data on δ-conotoxins are still very limited and further studies are
needed to elucidate the exact binding site(s) and mechanism of
action of δ-conotoxins and to determine if other toxins apart from
δ-conotoxins bind to this site.
REVISION OF NEUROTOXIN BINDING SITES
In the past, the classical nomenclature of neurotoxin binding sites
has been a valuable tool for the investigation and classiﬁcation of
neurotoxins.However,more andmore evidence emerges that these
sites can not be as strictly delineated as once was believed (Cat-
terall, 1980) and therefore the need for a revision of the binding
sites comes forth. We would like to suggest a preliminary revision
of the nomenclature of the neurotoxin binding sites, but are aware
of the new insights that soon will be extracted from the recently
discovered bacterial sodium channel crystal structure (Payandeh
et al., 2011) which will deﬁnitely help in further revisions of the
binding sites.
The revised binding site model can speciﬁcally signify a huge
simpliﬁcation of the conventional site 3 and site 4 since their cur-
rent pharmacological proﬁles become more and more complex
(Billen et al., 2010; Bosmans and Swartz, 2010; Liu et al., 2011).
In general, the location of the site 4 binding area in the revised
model can remain identical to the conventional site 4, located
at DII, comprising the extracellular linkers between S1–S3 and
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S3–S4. The same is valid for the revised site 3, remaining located
at the conventional S3–S4 linker of DIV. Because of the increas-
ing number of toxins displaying a structure–function relationship
incompatible with the conventional binding site model, we pro-
pose an adjusted model that can provide a more straightforward
and deﬁnite description of the binding sites, which will help us to
further clarify the missing parts in the puzzle of VGSC’s structure
and function.
As mentioned in the section about site 1, μO-conotoxins (e.g.,
MrVIA and MrVIB) and some spider toxins (e.g., HWTX-IV)
were at ﬁrst considered to be site 1 toxins, as they exhibit the
same effects as the conventional site 1 toxins. Nevertheless, these
toxins are nowadays believed to bind at site 4 or close by. For
μO-conotoxins for example, it was proven that they do not com-
pete with STX for site 1 (Terlau et al., 1996). On the contrast,
it was shown that they compete functionally with some classical
β-scorpion toxins for modiﬁcation of VGSCs and therefore are
suggested to share, at least partially, a binding site similar to the
classical deﬁned site 4. However, in contrast to β-scorpion toxins
that trap the S4 of DII in its outward position,μO-conotoxins will
rather bind to the S4 voltage sensor in its inward position. As such
they prevent the outward movement of the voltage sensor upon
membrane depolarization and hence prevent the channels from
opening, causing an inhibition of the Na+ conductance (Leipold
et al., 2007). Another example of a toxin interacting in the same
way with site 4, is represented by the spider toxin Huwentoxin-IV
(Xiao et al., 2008).
In the conventional deﬁnition, a site 4 neurotoxin is a toxin that
(1) binds to an extracellular region on the channel, formed by the
S3–S4 loop of DII, and (2) causes a hyperpolarizing shift in the
voltage-dependence of the activation. However, the two examples
mentioned in the previous paragraph, serve as prove that it makes
sense to uncouple these two conditions. Instead, a site 4 neurotoxin
could be deﬁned by using only the ﬁrst condition, indicating the
toxin’s main “binding area.”The effect that a site 4 neurotoxin can
cause could be the classical site 4 effect, a hyperpolarizing shift in
the activation, or the μO-conotoxin/HWTX-IV effect of inhibit-
ing Na+ conductance. This effect will depend on speciﬁc residues
or core regions that the toxin contains.
To deﬁne the main binding area one should be aware of the
many contact points that a toxin can have on the VGSC, while
only a few of them will be responsible for the exposed effects. To
which binding area or “site” a toxin is assigned, should therefore
only depend on which contact point causes the essential func-
tional effect. Other contact points on the VGSC can rather be
seen as anchor points, leading to non-functional binding of the
toxin or serving as subtype-selective recognition sites for the toxin.
Nevertheless, these non-functional contact points can also be a
requirement for the full activity of the toxin. He et al. (2011)
recently described this for binding of BmK IT2, a site 4 insect
β-toxin from Buthus martensii Karsch, to insect DmNav VGSCs.
Mutations in the site 4 binding area (DII S3–S4) largely abolished
the functional action of BmK IT2 on DmNav. However, some
anchor points in DIII turned out to be responsible for the selective
recognition of the insect channel over the rat Nav1.2 channel. In
addition, the N-terminal part of the S5–S6 linker (SS2–S6) in this
DIII greatly inﬂuenced the potency of the BmK IT2 binding to
DmNav (He et al., 2011).
In competitive binding experiments, the occupancy of the func-
tional binding area of a radiolabeled toxin can be diminished by
another toxin that also recognizes this contact point, as it is one of
its anchor points but not its functional binding area. On a macro-
scopic level this may raise the impression that the non-labeled
toxin has an identical functional effect as the labeled toxin. In the
proposed model however, the competitive binding of the displac-
ing non-labeled toxin, does not necessarily correlates this contact
point on the VGSC with the functional binding area of the non-
labeled toxin. This can explain the apparent paradox as is the case
for site 3 toxins like BmK I and BmK αIV (α-like scorpion toxins
from B. martensii Karsch) that can displace radiolabeled site 4 tox-
ins like BmK AS (β-like scorpion toxin) and BmK IT2 (depressant
insect β-scorpion toxin) respectively (Li et al., 2000; Chai et al.,
2006). For a comprehensive review on BmK toxins and another
binding model for the complex sites 3 and 4 (see Billen and Tytgat,
2009; Liu et al., 2011).
Another group of toxins pleading for the revision of VGSC
binding sites is that of the spider toxins β/δ-agatoxins, mentioned
in the section about site 4. Thorough electrophysiological charac-
terization of these toxins showed that both activation and inacti-
vation of an insect VGSC is affected when the toxin is applied. The
voltage-dependence of activation is shifted towards more hyper-
polarized potentials and a non-inactivating persistent current is
induced. In the classical view these effects suggest toxin binding
to site 4 and site 3, respectively. Therefore it is difﬁcult to “match”
the toxin to one of those binding sites as both effects can never
correlate with one of these classical deﬁned sites. This problem is
solved in the revised binding site model, as this does not couple
the effects of a toxin to its binding site. Therefore, as long as other
experimental evidence is lacking, β/δ-agatoxins could eventually
be stated to be site 4 toxins based on their high sequence homology
with site 4 δ-palutoxins (Billen et al., 2010). Moreover, it is more
likely that the effect on the inactivation is a result of toxin biding
at site 4 rather than that the effect on activation is an effect of toxin
binding at site 3. As experimental data are still lacking at this point,
these suggestions still have be conﬁrmed in future experiments.
The revised binding model also provides additional insights in
the recently developed innovative concept of transferring voltage
paddles of the VGSC Nav1.2 into fourfold symmetric potassium
(Kv) channels (Bosmans et al., 2008). With these chimeric chan-
nels, the individual contribution of all four voltage paddles to toxin
binding can be elucidated. Binding of the α-scorpion AaHII to the
chimeric channels clearly involves only the paddle motif of DIV,
which ﬁts with the (revised) deﬁnition of site 3. Binding of the β-
scorpion toxin revealed a less conventional pattern in which DII,
III, and IV are all involved in toxin binding. Nevertheless, with
the revised binding site model this can easily be explained and
a distinction can be made between the toxin’s functional bind-
ing area, located at the voltage paddle of DII, and its additional
anchor points, located at DIII and DIV. If only one of the toxin’s
contact points is transplanted into a Kv channel to prove the orig-
inal VGSC’s sensitivity to the toxin, it makes sense to suggest that
sensitivity of the chimeric channel to the applied toxin will be
www.frontiersin.org November 2011 | Volume 2 | Article 71 | 9
Stevens et al. Neurotoxin binding areas on VGSCs
induced anyway, no matter if the contact point is the functional
binding area, or an additional anchor point.
In the same article, the interesting spider toxins ProTx-I and
ProTx-II (Thrixopelma pruriens) are found to interact with DII
and DIV of Nav1.2 and ProTx-I also displayed an interaction with
DI of Nav1.2. Which domain comprises the main binding area
for these toxins and which can serve as anchor point still remains
the topic of discussion. Recently, Smith et al. (2007) conducted a
thorough mutagenesis study of several predicted key residues in
site 3 and 4 of the Nav1.5VGSC isoform. Contrary to the results in
Nav1.2, no main binding area could be detected. At the same time,
they investigated which residues in ProTx-II were essential for its
activity. The most important residues were hydrophobic and basic
amino acids, making the bioactive surface amphiphatic in nature.
This raises the exciting possibility that a yet undeﬁned binding
area or contact point exists, not located on the VGSC itself but
somewhere in the surrounding membrane. This possibility was
previously explored for Kv channels in several studies, examining
for example partitioning of several toxins into model membranes
(Milescu et al., 2007). All together, it was shown that a number of
spider toxins do partition into membranes and that the compo-
sition of membrane lipids inﬂuences toxin effects. On the other
hand, Cohen et al. (2006) demonstrated for several β-scorpion
toxins that they do not interact with any binding area at the phos-
pholipid bilayer. It should be noted however, that the tested spider
toxins are members of a growing class of promiscuous toxins that
not only target a particular class of ion channels but instead seem
to bind to the voltage sensors of several classes of ion channels
(e.g., Hanatoxin binds to several members of the Kv, Cav, and Nav
ion channel families, a detailed list of other promiscuous toxins
can be found in Bosmans and Swartz, 2010). This could indicate
that themechanismof action and the binding area of promiscuous
spider toxins differ from β-scorpion toxins and that an unidenti-
ﬁed contact point in the lipid membrane may be responsible for
at least part of the full activity of the ProTx-I and ProTx-II spider
toxins. Interaction between the spider toxin and the VGSC may
then result in a tri-molecular complex, comprising the toxin, and
contact points at the voltage sensor and at the lipid membrane
(Bosmans and Swartz, 2010).
Additional evidence for the inﬂuence of other contact points
in the near environment of VGSC α-subunits resulted from recent
experiments, investigating the inﬂuence of the expressedβ-subunit
on the action of μO-conotoxin MrVIB. Wilson et al. (2011) dis-
covered that expression of Nav1.8 channels with four different
β-subunits resulted in a higher-afﬁnity block of MrVIB compared
to the α-subunit on its own. Contrary to this ﬁnding, the afﬁn-
ity of STX turned out to be independent of coexpression with
β-subunits. One of their suggested mechanistic explanations for
the inﬂuence of β-subunit expression on toxin function is that
MrVIB could have a certain contact point on these β-subunits
that contributes to its action. Further structure–function studies
are necessary to conﬁrm if the interaction between toxin and β-
subunit is speciﬁc forμO-conotoxins or rather is the case for other
toxins – apart from the guanidinium toxins, as well.
CONCLUSION AND FURTHER PERSPECTIVES
In the past, neurotoxins already have proven to be indispensible
tools for the exploration of the structure and function of VGSCs.
The long awaited elucidation of the crystal structure of the bacte-
rial VGSC NavAb (Payandeh et al., 2011) certainly inaugurates a
newera inVGSCresearch andwill help toprovidenew insights into
neurotoxin binding toVGSCs. Further examination of toxin–lipid
interactions and toxin–β-subunit interactions, determination of
the bioactive core of neurotoxins and detailed mutagenesis studies
with possible key residues for neurotoxin binding are just a grasp
out of the possible experiments of which we may gain interesting
new concepts for VGSCs.
With our revised model for neurotoxin binding sites on VGSC
we try to address the growing problems that arise with the tradi-
tional classiﬁcation of neurotoxin binding sites. The uncoupling of
the toxin’s functional outcome from its binding area should help
to get a more clear-cut classiﬁcation of neurotoxins. However, to
distinguish the toxin’s main binding area from additional anchor
points, one should not make preliminary conclusions by linking
the effects of the toxin immediately to its binding area, nor should
one deduct site classiﬁcation or function of new toxins solely based
on homology with other toxins. Therefore all available techniques
(e.g., mutagenesis studies, chimeric channels, electrophysiological
characterization) should be optimally used to characterize a toxin
and its putative binding area on the channel.
Naturally occurring neurotoxins can be considered as valu-
able and promising tools, not only to further unravel structure–
functionofVGSCsbut they also can serve as lead compounds in the
development of novel drugs. Considering the fact that malfunc-
tioning of VGSCs underlies a large range of diseases like epilepsy,
neuropathic pain, and long QT syndrome, there is an urgent need
for molecules that can selectively and potently target these mem-
braneproteins. Thequest for suchmolecules can start at the venom
and poisons of organisms, providing us an almost endless library
of possible lead compounds.
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